Children's Hospital is part of the UPMC family.
Be safe anytime, anywhere.
To find a pediatrician or pediatric specialist, please call 412-692-7337 or search our directory.
A resource for our network of referring physicians.
For more information about research, please call our main office at 412-692-6438.
Download our mobile app today - it's free!
Researchers used fluorographic imaging to analyze treated and untreated liver cells from a mouse models to identify autophagosomes (green), cell parts that aid in enzymatic digestion. New laboratory studies suggest that a drug for the treatment of seizures may also eliminate the most common genetic cause for which children undergo liver transplants, α1-antitrypsin (AT) deficiency. Based on these studies, researchers believe the drug may even be able to address other diseases with similar traits.
Learn about the pilot study: Alpha-1 Antitrypsin Deficiency Study – Phase II
In most people, the liver produces normal AT, a protein carried through the bloodstream for use by cells in other organs. In the classic form of AT deficiency, which affects 1 in 3,000 births, a gene mutation causes the liver to instead produce an abnormal protein, ATZ, which builds up in liver cells. This eventually leads to fibrosis, or scarring, of the organ and sets the stage for tumor development. The disease sometimes doesn’t show itself until adulthood, when the liver starts to fail due to cirrhosis or cancer.
Although carbamazepine is used to treat seizure disorders, recent work suggested it could enhance a natural cellular pathway, the digestive process called autophagy. On that basis, the research team reasoned that the drug might be able to rid cells of toxic ATZ. When they treated ATZ cell lines with carbamazepine in the lab, they observed a marked decrease in ATZ, because the abnormal proteins degraded more quickly via autophagy.
Those cell tests led to experiments with mouse models with AT deficiency. Again the amount of ATZ decreased in mice treated with carbamazepine.
The most amazing finding was that the drug reversed the fibrosis in the livers of mice, and after two weeks of treatment, the liver tissue resembled that of a healthy mouse.
Because the anti-seizure drug, which is also known by the brand name Tegretol, is well understood by the medical community, researchers suggest that clinical trials can be rapidly initiated.
The implication that carbamazepine can step-up a cell’s autophagy machinery might have value in other disorders, such as Alzheimer’s disease, Huntington’s disease and Parkinsonism, all of which are thought to be caused by toxic effects of proteins clumping in the brain. The research team are exploring these possibilities in preclinical studies.
The research team, whose findings were published in Science, included lead author Tunda Hidvegi, PhD, Department of Pediatrics, Simon C. Watkins, PhD, Department of Cell Biology and Physiology, George Michalopoulos, MD, PhD, Department of Pathology and other researchers from the University of Pittsburgh School of Medicine.
Children's Hospital's main campus is located in the Lawrenceville neighborhood. Our main hospital address is:
UPMC Children’s Hospital of Pittsburgh
One Children’s Hospital Way
4401 Penn Ave.
Pittsburgh, PA 15224
In addition to the main hospital, Children's has many convenient locations in other neighborhoods throughout the greater Pittsburgh region.
With myCHP, you can request appointments, review test results, and more.
For questions about a hospital bill call:
To pay your bill online, please visit UPMC's online bill payment system.
Interested in giving to Children's Hospital? Visit Children's Hospital of Pittsburgh Foundation's website to make a donation online.